Allianz Asset Management
IGMS

Allianz Asset Management’s IGM Biosciences IGMS Stock Holding History

Allianz Asset Management’s Portfolio IGMS Stock Details IGMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-14,325
Closed -$942K – 2611
2021
Q3 		$942K Buy
14,325
+2,500
+21% +$191K ﹤0.01% 1959
2021
Q2 		$984K Sell
11,825
-2,000
-14% -$148K ﹤0.01% 1747
2021
Q1 		$1.06M Buy
+13,825
New +$1.26M ﹤0.01% 1619
2020
Q3 		– Sell
-14,608
Closed -$1.07M – 2109
2020
Q2 		$1.07M Buy
+14,608
New +$887K ﹤0.01% 1807

Other funds holding IGMS

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Allianz Asset Management's IGMS Position: Q4 2021 in Review

Allianz Asset Management sold out of IGM Biosciences (IGMS) in Q4 2021, closing a stake of 14,325 shares — an estimated $942K sold.

Allianz Asset Management first reported a position in IGMS in Q2 2020 and held it in 4 quarters. The position peaked at $1.07M in Q2 2020. 87 funds tracked by Wall St. Rank hold IGMS as of Q4 2021.

  • Allianz Asset Management reported no remaining IGM Biosciences position as of Q4 2021 after selling out during the quarter.
  • Allianz Asset Management sold 14,325 IGM Biosciences shares in Q4 2021, an estimated $942K.
  • Allianz Asset Management first reported a position in IGM Biosciences in Q2 2020 and held it in 4 quarters.
  • Allianz Asset Management's IGM Biosciences position peaked at $1.07M in Q2 2020.
  • 87 funds tracked by Wall St. Rank held IGM Biosciences as of Q4 2021.

Based on Allianz Asset Management's 13F filing for Q4 2021, filed 11 Feb 2022.